Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Ethylcellulose-A Pharmaceutical Excipient with Multidirectional Application in Drug Dosage Forms Development.

Wasilewska K, Winnicka K.

Materials (Basel). 2019 Oct 17;12(20). pii: E3386. doi: 10.3390/ma12203386. Review.

2.

How to Modify Drug Release in Paediatric Dosage Forms? Novel Technologies and Modern Approaches with Regard to Children's Population.

Trofimiuk M, Wasilewska K, Winnicka K.

Int J Mol Sci. 2019 Jun 29;20(13). pii: E3200. doi: 10.3390/ijms20133200. Review.

3.

How to assess orodispersible film quality? A review of applied methods and their modifications.

Wasilewska K, Winnicka K.

Acta Pharm. 2019 Jun 1;69(2):155-176. doi: 10.2478/acph-2019-0018. Review.

PMID:
31259725
4.

Ethylcellulose in Organic Solution or Aqueous Dispersion Form in Designing Taste-Masked Microparticles by the Spray Drying Technique with a Model Bitter Drug: Rupatadine Fumarate.

Wasilewska K, Szekalska M, Ciosek-Skibinska P, Lenik J, Basa A, Jacyna J, Markuszewski M, Winnicka K.

Polymers (Basel). 2019 Mar 20;11(3). pii: E522. doi: 10.3390/polym11030522.

5.

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM; REDUCE-IT Investigators.

N Engl J Med. 2019 Jan 3;380(1):11-22. doi: 10.1056/NEJMoa1812792. Epub 2018 Nov 10.

PMID:
30415628
6.

Taste-masking assessment of orally disintegrating tablets and lyophilisates with cetirizine dihydrochloride microparticles.

Amelian A, Wasilewska K, Wesoły M, Ciosek-Skibińska P, Winnicka K.

Saudi Pharm J. 2017 Dec;25(8):1144-1150. doi: 10.1016/j.jsps.2017.06.001. Epub 2017 Jun 19.

7.

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.

Mathieu C, Dandona P, Gillard P, Senior P, Hasslacher C, Araki E, Lind M, Bain SC, Jabbour S, Arya N, Hansen L, Thorén F, Langkilde AM; DEPICT-2 Investigators.

Diabetes Care. 2018 Sep;41(9):1938-1946. doi: 10.2337/dc18-0623. Epub 2018 Jul 19.

PMID:
30026335
8.

Influence of ALA-mediated photodynamic therapy on secretion of interleukins 6, 8 and 10 by colon cancer cells in vitro.

Kawczyk-Krupka A, Czuba Z, Latos W, Wasilewska K, Verwanger T, Krammer B, Sieroń A.

Photodiagnosis Photodyn Ther. 2018 Jun;22:137-139. doi: 10.1016/j.pdpdt.2018.02.021. Epub 2018 Mar 3.

PMID:
29510260
9.

Application of standard cell cultures and 3D in vitro tissue models as an effective tool in drug design and development.

Amelian A, Wasilewska K, Megias D, Winnicka K.

Pharmacol Rep. 2017 Oct;69(5):861-870. doi: 10.1016/j.pharep.2017.03.014. Epub 2017 Mar 23. Review.

PMID:
28623710
10.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group.

N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.

11.

[Albuminuria in patients with type 2 diabetes mellitus in relation to percentage of HbA1c].

Kamińska J, Koper OM, Czyzewska J, Wasilewska K, Kemona H.

Pol Merkur Lekarski. 2012 May;32(191):302-5. Polish.

PMID:
22779336
12.

[Assess the impact of concentrations of inflammatory markers IL-6, CRP in the presence of albuminuria in patients with type 2 diabetes].

Czyzewska J, Wasilewska K, Kamińska J, Koper O, Kemona H, Jakubowska I.

Pol Merkur Lekarski. 2012 Feb;32(188):98-102. Polish.

PMID:
22590912
13.

Porcine skin as a model system for studies of adverse effects of narrow-band UVB pulses on human skin.

Brozyna A, Wasilewska K, Wesierska K, Chwirot BW.

J Toxicol Environ Health A. 2009;72(13):789-95. doi: 10.1080/15287390902800363.

PMID:
19557606

Supplemental Content

Loading ...
Support Center